Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Nov 20, 2019 4:00pm

169 Views

Post# 30375493

RE:RE:RE:RE:RE:It feels like something is brewing here..

winr88 wrote
I think your timing for today's buy is excellent. My sense tells me that FDA news is very close

Hi winr88 ... yeah you would think the FDA if issues needed clarity should've been done in the first 3 weeks maybe into the 4th week at most. Again using a reliable source and also echoed by a few here the canadian health approval is the most ridged in the world and if FDA concerns arose it would be far less then those of Canada also told that the European approval is somewhat that of the Americans. So coming back to time of approval from the FDA could very well be as I think you said any day or am I putting words in your mouth?

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario